Alnylam Pharmaceuticals | ALNY

Aktienkurs
286.58
Täglich Wechseln
-2.81 -0.97%
Monatlich
-1.68%
Jährlich
-6.95%
Q2 Prognose
297.05

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-04-30 FY2026Q1 AM 1.99 0.99 -0.01
2026-02-12 FY2025Q4 AM 1.25 1.27 0.06
2025-10-30 FY2025Q3 AM 2.90 0.27 -0.50
2025-07-31 FY2025Q2 AM 0.32 -0.73 0.56
2025-05-01 FY2025Q1 AM -0.01 -0.94 -0.16



Preis Chg Tag Jahr Datum
Takeda 5,082.00 49.00 0.97% 16.85% 2026-06-12
Acadia Pharmaceuticals 21.38 -0.01 -0.05% -1.52% 2026-06-12
Agios Pharmaceuticals 29.52 0.80 2.79% -13.94% 2026-06-12
Alnylam Pharmaceuticals 286.58 -2.81 -0.97% -6.95% 2026-06-12
Amgen 354.07 0.01 0% 19.93% 2026-06-12
Arrowhead Research 74.16 -0.25 -0.34% 371.16% 2026-06-12
Tectonic Therapeutic 29.11 -0.23 -0.78% 32.98% 2026-06-12
BioCryst Pharmaceuticals 8.65 0.15 1.71% -16.63% 2026-06-12
BioMarin Pharmaceutical 55.92 0.38 0.68% -0.53% 2026-06-12
Incyte 108.69 0.86 0.80% 60.43% 2026-06-12

Preis Tag Jahr Datum
USND 25868 58.12 0.23% 33.29% 2026-06-12